ERBB2 and invasive ductal breast carcinoma: Our present study demonstrated higher expression frequencies of MAGEA, NY-ESO-1 and other CT antigens in the ER-negative group, including the ER/PR/HER2 triple-negative subgroup, of invasive ductal carcinoma.